The Symani system aims to address the challenges of microsurgery with its NanoWrist instruments. These instruments help to access and suture small, delicate anatomies. That includes veins, arteries, nerves and lymphatic vessels as small as 0.3mm in diameter. It provides motion scaling and tremor reduction to allow precise micro-movements.
Pisa, Italy-based MMI’s Symani received CE mark in 2019, and the company continues to work on U.S. commercialization. The first-of-its-kind robotic technology enables expanded adoptions for patients in need of sot tissue open surgical procedures.
Now, since its first-in-human cases in October 2020, Symani surpasses the 500-procedure milestone. MMI says it rapidly increases patient access to surgical treatment options as surgeons become more comforta…